Cargando…

Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer

BACKGROUND: LRIG1, the founding member of the LRIG (leucine-rich repeat and immunoglobulin-like domain) family of transmembrane proteins, is a negative regulator of receptor tyrosine kinases and a tumour suppressor. Decreased LRIG1 expression is consistently observed in cancer, across diverse tumour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umeh-Garcia, Maxine, O’Geen, Henriette, Simion, Catalina, Gephart, Melanie Hayden, Segal, David J., Sweeney, Colleen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346006/ https://www.ncbi.nlm.nih.gov/pubmed/35440669 http://dx.doi.org/10.1038/s41416-022-01812-8

Ejemplares similares

LRIG1 opposes epithelial to mesenchymal transition and inhibits invasion of basal-like breast cancer cells
por: Yokdang, Nucharee, et al.
Publicado: (2015)

Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha
por: Frietze, Seth, et al.
Publicado: (2014)

Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing
por: O’Geen, Henriette, et al.
Publicado: (2022)

Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer
por: Amir, Sumaira, et al.
Publicado: (2016)

Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth
por: Morrison, Meghan M., et al.
Publicado: (2015)

A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture
por: O'Geen, Henriette, et al.
Publicado: (2015)

Unexpected binding behaviors of bacterial Argonautes in human cells cast doubts on their use as targetable gene regulators
por: O’Geen, Henriette, et al.
Publicado: (2018)

Author Correction: Methods for Scarless, Selection-Free Generation of Human Cells and Allele-Specific Functional Analysis of Disease-Associated SNPs and Variants of Uncertain Significance
por: Coggins, Nicole B., et al.
Publicado: (2018)

Methods for Scarless, Selection-Free Generation of Human Cells and Allele-Specific Functional Analysis of Disease-Associated SNPs and Variants of Uncertain Significance
por: Coggins, Nicole B., et al.
Publicado: (2017)

Imaging Unique DNA Sequences in Individual Cells Using a CRISPR-Cas9-Based, Split Luciferase Biosensor
por: Heath, Nicholas G., et al.
Publicado: (2022)

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

LRIG and cancer prognosis
por: Lindquist, David, et al.
Publicado: (2014)

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2020)

dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression
por: O’Geen, Henriette, et al.
Publicado: (2017)

A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer
por: Deng, Jiaojiao, et al.
Publicado: (2021)

LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
por: Wang, Y, et al.
Publicado: (2013)

ZNF274 Recruits the Histone Methyltransferase SETDB1 to the 3′ Ends of ZNF Genes
por: Frietze, Seth, et al.
Publicado: (2010)

LRIG1 expression and colorectal cancer prognosis
por: Bakherad, Maryam, et al.
Publicado: (2021)

The Prognostic Role of LRIG Proteins in Endometrial Cancer
por: Razumova, Zoia, et al.
Publicado: (2021)

Effects on the transcriptome upon deletion of a distal element cannot be predicted by the size of the H3K27Ac peak in human cells
por: Tak, Yu Gyoung, et al.
Publicado: (2016)

Aberrant methylation and silencing of the SPINT2 gene in high‐grade gliomas
por: Fukushima, Tsuyoshi, et al.
Publicado: (2018)

Lrig1 expression identifies airway basal cells with high proliferative capacity and restricts lung squamous cell carcinoma growth
por: Succony, Laura, et al.
Publicado: (2022)

Lrig1 Expression in Human Sebaceous Gland Tumors
por: Pünchera, Jöri, et al.
Publicado: (2016)

Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
por: O’Geen, Henriette, et al.
Publicado: (2019)

Vertebrate Lrig3-ErbB Interactions Occur In Vitro but Are Unlikely to Play a Role in Lrig3-Dependent Inner Ear Morphogenesis
por: Abraira, Victoria E., et al.
Publicado: (2010)

Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation
por: Medress, Zachary, et al.
Publicado: (2015)

Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells
por: Adhikari, Anna, et al.
Publicado: (2021)

Artificial escape from XCI by DNA methylation editing of the CDKL5 gene
por: Halmai, Julian A N M, et al.
Publicado: (2020)

USP8 modulates ubiquitination of LRIG1 for Met degradation
por: Oh, Young Mi, et al.
Publicado: (2014)

Lrig1 is a positive prognostic marker in hepatocellular carcinoma
por: Yang, Bo, et al.
Publicado: (2016)

LRIG2 regulates cell proliferation, migration and apoptosis of osteosarcoma
por: Li, Zhi-Qiang, et al.
Publicado: (2022)

Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours
por: Murai, M, et al.
Publicado: (2005)

Aberrant methylation and silencing of IRF8 expression in non-small cell lung cancer
por: SUZUKI, MAKOTO, et al.
Publicado: (2014)

Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence
por: Wilting, Saskia M., et al.
Publicado: (2016)

LRIG1 is a gatekeeper to exit from quiescence in adult neural stem cells
por: Marqués-Torrejón, María Ángeles, et al.
Publicado: (2021)

Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain
por: Bailus, Barbara J, et al.
Publicado: (2016)

LRIG2 expression and prognosis in non-small cell lung cancer
por: WANG, GUANGCHUAN, et al.
Publicado: (2014)

Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
por: Rondahl, Veronica, et al.
Publicado: (2013)

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
por: Mao, Feng, et al.
Publicado: (2018)

LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer
por: Lindquist, David, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v54e688keimshmnic1rv821ea3